The era of minimally invasive glaucoma surgery

眼压越高,视神经损伤的可能性越大,降低眼压对于延缓青光眼进程具有重要的意义.目前,青光眼治疗的策略主要是降低眼压,而手术是能达到降低眼压目的的重要手段.临床广泛应用的经典术式为联合丝裂霉素C的小梁切除术,降眼压效果明确,但可能存在严重并发症,这促使眼科医师致力于寻求创伤更小的降眼压术式.微创性青光眼手术(MIGS)技术发展日新月异,经内路操作包括准分子激光小梁切开术、iStent植入术、小梁消融术、Cypass支架植入术和Hydrus Schlemm管支架植入术等.经外路操作的术式包括黏小管成形术,此外还有经非传统途径的Solx金质分流器植入术等.该文根据操作方式的不同,综述新近出现的MIGS方式,提示广大读者青光眼微创时代已经到来.The chance of glaumatic optic nerve injury increases with the intraocular pressure.Reducing the intraocular pressure has an important significance for slowing the process of glaucoma.Surgery is one of the most important means to lower the intraocular pressure.With the classic operation of the joint of mitomycin C trabeculectomy,the intraocular pressure reduce,but serious complications may occur,which prompts ophthalmologists to seek less traumatic effects in the operation.The minimally invasive glaucoma surgery (MIGS) develop rapidly recently,and these technologies include the ab internal operations,such as excimer laser trabeculotomy,iStent implantation,trabectome,Cypass stent implantation,Hydrus Schlemm canal stent implantation,etc.The ab external operations,such as canaloplasty and via non-traditional ways operations,such as Solx gold shunt implantation,etc.According to the different methods of operation,this paper reviewed the latest MIGS.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)111052-10563